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1. Introduction 
Hepatocellular carcinoma (HCC) usually shows a typical gross appearance and the gross 
classification and gross diagnosis of resected specimens is performed as routine clinical work. 
In the authors’ institution, many surgical cases of HCC are encountered, including rare and 
unusual cases. This chapter documents the gross classification, features and diagnosis of usual 
and unusual HCCs with representative gross photographs and a review of the literature. 
2. Gross findings 
The gross appearances of HCCs are affected by various factors such as tumor size, tumor 
thrombus in the portal and hepatic veins, intrahepatic metastasis, necrosis and hemorrhage. 
Well-differentiated HCC often produces bilirubin and the tumor color will be greenish after 
formalin fixation. On the other hand, poorly differentiated HCC usually shows a whitish 
coloration on gross appearance. If the tumor is accompanied by steatosis, the tumor will be 
yellowish in color. HCC frequently presents with a nodular appearance showing fibrous 
capsules and septa. The occurrence of capsule and septum formation is closely related to 
tumor size. Both capsule and septum are unusual in small HCCs less than 2.0 cm in 
diameter. In the majority of HCCs over 2.0 cm in diameter, the tumor grows expansively 
and a capsule and septum are formed. 
3. Gross classification of usual types of HCC 
3.1 Eggel’s classification 
Eggel’s classification [Eggel, 1901] was proposed more than 100 years ago, and has been 
widely used for the classification of autopsy cases, rather than surgical cases. This system 
classifies HCC into three major types according to gross appearance: nodular; massive; and 
diffuse. Nodular type consists of a single or multiple discrete nodular tumors with clear 
demarcation. Massive type is a large mass replacing almost the entire right or left lobe. 
Diffuse type is characterized by diffuse proliferation of numerous minute cirrhosis-like 
tumor nodules throughout the entire lobe or liver. 
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Fig. 1. Gross appearance of massive-type HCC in Eggel’s classification. 
3.2 Subclassification of nodular HCC 
Eggel’s classification is not applicable to many surgically resected HCCs. In order to cope with 
surgically resected HCCs, the Liver Cancer Study Group of Japan (LCSGJ) divided nodular 
HCC into three subtypes: simple nodular type; simple nodular type with extranodular growth; 
and confluent multinodular type [Kanai et al., 1987; LCSGJ, 1987]. The category of small 
nodular type with indistinct margin, as the typical gross appearance of early HCC, has 
recently been added to this subclassification [LCSGJ, 2000]. Several investigators have reported 
the predictive value of this subclassification, with favorable outcomes for simple nodular type 
compared to the other two subtypes in terms of recurrence and survival after hepatectomy 
[Hui et al., 2000; Shimada et al., 2001; Inayoshi et al., 2003]. 
 
Fig. 2. Schema for subclassification of nodular HCC on gross appearance 
3.2.1 Small nodular type with indistinct margins 
Grossly, small HCC less than about 2 cm in diameter can be classified into two major types: 
a small nodular type with indistinct margins (vaguely nodular type); and a distinctly 
nodular type [Kojiro & Nakashima, 1999]. The distinctly nodular type can be classified into 
one of the three subtypes: simple nodular type; simple nodular type with extranodular 
growth; and confluent multinodular type. On gross observation of the small nodular type 
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with indistinct margins, distinguishing an obscure tumor nodule from surrounding cirrhotic 
liver is sometimes difficult. Histologically, most tumors of small nodular type with 
indistinct margins consist of uniformly distributed well-differentiated cancerous tissue 
showing a characteristic replacing growth at the tumor boundary. Although portal tracts are 
retained within the nodule, the number is markedly reduced [Nakashima et al., 1999]. Many 
of the retained portal tracts are deformed due to varying degrees of tumor cell invasion, 
designated as “stromal invasion”, and this stromal invasion is regarded as the most helpful 
clue to distinguish small well-differentiated HCC from high-grade dysplastic nodules 
[Kondo et al., 1994, Tomizawa et al., 1995, Nakano et al, 1997]. Vascular invasion and 
intrahepatic micrometastasis are not usually observed in small nodular-type HCC with 
indistinct margins. Well-differentiated HCC of the small nodular type with indistinct 
margins has thus been designated as “early hepatocellular carcinoma”, to separate this 
particular type of HCC from the classical form of HCC [Kojiro, 2006, 2007]. 
 
Fig. 3. a) Gross appearance of small nodular type with indistinct margins. b) Characteristic 
replacing growth at the tumor boundary (hematoxylin and eosin (HE), 20). 
a
b
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3.2.2 Simple nodular type 
This is a well-demarcated nodule, frequently surrounded by a fibrous capsule. Grossly, 
extranodular tumor growth, intrahepatic metastasis, and/or vascular invasion are not 
observed. The inside of the tumor often shows a mosaic appearance due to fibrous septa. 
Small HCC of the distinctly nodular type is also included in this category. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Gross appearance of simple nodular type. A fibrous capsule and mosaic appearance 
due to fibrous septa are apparent. 
3.2.3 Simple nodular type with extranodular growth 
When a tumor of simple nodular type shows varying degrees of extranodular growth 
beyond the capsule, vascular invasion, and/or small metastases near the nodule, the tumor 
should be categorized as simple nodular type with extranodular growth. This criterion is not 
concerned with tumor size. Small tumors showing simple nodular type with extranodular 
growth sometimes need discrimination from confluent multinodular type and large tumors 
showing simple nodular type with extranodular growth sometimes need discrimination 
from massive-type HCC. 
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Fig. 5. Gross appearance of simple nodular type with extranodular growth. a) Small tumor 
of simple nodular type with extranodular growth. b) Large tumor of simple nodular type 
with extranodular growth. This type of tumor sometimes needs discrimination from 
massive-type and/or confluent multinodular-type HCC. 
3.2.4 Confluent multinodular type 
This is a tumor resulting from the joining together of a few to numerous small tumor 
nodules. No fibrous capsule is seen covering the entire tumor in this type and portal tracts 
are frequently entrapped between agglomerated small tumor nodules. The incidence of 
vascular invasion and/or intrahepatic metastasis is higher than in simple nodular types. 
Large confluent multinodular-type tumors sometimes need discrimination from massive-
type HCC. 
a
b
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Fig. 6. Gross appearance of confluent multinodular-type HCC. a) Small tumor of confluent 
multinodular type. b) Large tumor of simple confluent multinodular type. No fibrous 
capsule covering the entire tumor is present. 
4. Unusual gross types of HCC 
4.1 Scirrhous HCC 
About 5% of HCCs show a scirrhous growth pattern characterized by marked fibrosis along 
the sinusoid-like blood spaces with varying degrees of atrophy of the tumor trabeculae 
[Kurogi et al., 2006]. These tumors are subclassified as scirrhous HCC according to the WHO 
classification [Bosman et al., 2010]. Macroscopically, scirrhous HCCs are greyish-white, 
solid, lobulated, and unencapsulated, but well demarcated, stellate-shaped fibrosis is 
common. The gross appearance of scirrhous HCC mimics intrahepatic cholangiocarcinoma, 
a
b
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combined hepatocellular and cholangiocarcinoma, and fibrolamellar carcinoma. Scirrhous 
HCC is histologically distinguishable from fibrolamellar carcinoma, because the cancer cells 
do not differ from those of ordinary HCC. Scirrhous HCC should also not be confused with 
diffuse fibrosis (scirrhous change) in HCC, a well-known feature of cases treated by various 
anticancer therapies such as chemotherapy, irradiation and chemoembolization. 
Preoperatively, scirrhous HCC is often misdiagnosed as intrahepatic cholangiocarcinoma or 
metastatic carcinoma on diagnostic imaging, because of atypical imaging findings due to the 
diffuse fibrosis [Kojiro, 2006; Bosman et al., 2010]. 
 
Fig. 7. a) Gross appearance of scirrhous HCC. Stellate-shaped fibrosis is present. b) 
Histology of the scirrhous HCC. Marked fibrosis (blue) is apparent along the sinusoid-like 
blood spaces. Cancer cells are no different from ordinary HCC (Azan staining, 100). 
a
b
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4.2 Fibrolamellar HCC 
The clinical and pathological features of fibrolamellar HCC (FLC) were first described by 
Edmondson [Edmondson, 1958]. The term “fibrolamellar carcinoma” was proposed by 
Craig et al. [Craig et al., 1980], and has been adopted worldwide. FLC shows marked 
geographic variations in incidence, and is extremely rare in Asian countries, including Japan 
[Magata et al., 2001]. Soreide et al. [Soreide et al., 1986] reviewed 80 cases of FLC (including 
their own 9 cases) reported between 1980 and 1986. This entity most frequently occurs in 
noncirrhotic livers of adolescents or young adults with a mean age of 23 years; only 6% are 
over 50 years old. Two thirds of the cases of FLC involve the left lobe and prognosis is more  
 
Fig. 8. a) Gross appearance of fibrolamellar hepatocellular carcinoma. White fibrous septa 
forming a central scar, lobulated appearance, and greenish coloration due to bile production 
can be observed. b) Tumor cells display abundant polygonal and deeply eosinophilic 
cytoplasm and characteristic lamellar fibrosis is observed (HE, 200). 
a
b
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favorable than that of classical HCC. Grossly, the tumor is well demarcated but 
nonencapsulated and is light brown, tan or gray. The tumor is occasionally partially 
greenish due to bile production. Glistening white fibrous septa, sometimes forming a 
central scar, give the tumor a lobulated appearance. This gross appearance mimics focal 
nodular hyperplasia. Histologically, this particular type of HCC consists of tumor cells 
growing in sheets or small trabeculae, which are separated by fibrous collagen with a 
characteristic lamellar pattern of variable thickness and frequent hyalinization. Tumor 
cells display abundant polygonal and deeply eosinophilic cytoplasm and a distinct 
nucleolus. Intracytoplasmic inclusions, such as “pale bodies” that show 
immunohistochemically positive results for antifibrinogen and PAS-positive globules, are 
frequently observed [Ishak et al., 1999]. 
4.3 Green HCC 
Nodular-type HCC accompanied by prominent bile production shows a yellowish 
coloration on a fresh specimen and deep greenish coloration after formalin fixation. Such 
tumors are generally called “green HCC”. 
 
Fig. 9. Gross appearance of green HCC. 
4.4 Pelioid type of HCC 
Peliosis hepatis-like blood-filled cavities are frequently observed in HCC. HCC with this 
finding is generally called “HCC with peliotic change” or “pelioid-type HCC” [Ishak et al., 
1999]. Another characteristic of HCC with peliotic change is that all tumors are completely 
or incompletely encapsulated. Several cases of extensive pelioid-type HCC have been 
reported [Kim, 2007, Hoshimoto, 2009, Kai, 2011]. Grossly, extensive pelioid-type HCC 
mostly consists of well-defined black-nodular components. Histologically, peliotic change is 
distinguished from hemorrhage by the presence or absence of degenerative changes and/or 
necrosis. In general, degenerative changes and/or necrosis are observed around 
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hemorrhage in HCC tumors. On the other hand, the tumorous tissue around peliotic change 
is not at all degenerative or necrotic, and blood is localized within the spaces with clear 
margins. However, when peliotic change becomes extensive, rupture may occur and 
hemorrhage may develop [Kojiro, 2006]. 
 
Fig. 10. a) The gross appearance of pelioid-type HCC. The tumor comprises well-defined 
black nodular components and white nodular components. b) Histologically, extensive 
pelioid change is apparent in the tumor tissue (HE, 25). 
4.5 Intraductal growth type of HCC 
Rarely, HCC shows growth into the hepatic bile duct and/or common bile duct, causing 
progressive obstructive jaundice. In 1972, Lin [Lin, 1972] designated such cases as “icteric 
HCC”. The reported incidence of icteric HCC varies from 0.2% to 5.4% in patients with HCC 
a
b
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[Kojiro et al., 1982; Huang et al., 1998]. Although intraductal tumor growth of HCC was once 
considered rare, advances in diagnostic imaging have revealed many cases of HCC presenting 
with intra-bile-duct growth [Kirk et al., 1994; Soyer et al., 1995; Wang et al., 2002]. Patients with 
the intraductal growth type of HCC rarely show no obvious intrahepatic tumor. Postoperative 
pathological examinations confirm the bile duct nodules causing obstructive jaundice as HCC. 
This type of HCC is difficult to diagnose, and only a few cases have been reported [Long et al., 
2010]. In some cases, massive hemorrhage in the bile duct (hemobilia) forms due to tumor 
growth and can cause rapid death on rare occasions [Kojiro, 2006]. Huang et al. [Huang et al., 
1998] stated that the prognosis might be improved if surgical resection of the tumor cast is 
performed at an earlier stage. In fact, many cases have been reported with good prognosis 
after tumor cast resection [Chen et al., 1994; Lau et al., 1997; Hu et al., 1999]. 
 
Fig. 11. a) Gross appearance for the intraductal growth type of HCC. This case shows no 
obvious intrahepatic mass lesion. b) Tumor cells with blood clot in dilated bile ducts (HE, 20). 
a
b
www.intechopen.com
 Hepatocellular Carcinoma – Clinical Research 
 
166 
4.6 Spontaneous regression of HCC 
Spontaneous massive necrosis or regression of HCC is a very rare event. The precise 
mechanisms underlying spontaneous regression of HCC remain unclear, but various factors  
 
Fig. 12. a) Cut surface of the resected liver in a case of spontaneous regression. Yellow-white 
nodular lesions and brownish lesions coexist. The HCC measuring 11 cm in diameter 
showed a significant reduction to 3.7 cm after angiography. b) Coagulative necrosis and 
inflammatory granulation tissue are apparent in the nodule and small foci of viable HCC 
cells are observed in another specimen (HE, 40). 
a
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have been speculated to play a role, such as alcohol withdrawal, androgen withdrawal, and 
intake of herbal medicines [Gottfried et al., 1982; Lam et al., 1982; McCaughan et al., 1985]. 
Secondary stimulation of cytokine production by tumor necrosis or bacterial infection has 
also been suggested to contribute to spontaneous regression [Watanabe et al., 1994; 
Markovic et al., 1996]. Another important factor might be insufficient blood supply to the 
tumor, possibly due to rapid natural tumor growth, spontaneous arterial thrombosis, 
thickened fibrous capsule or gastrointestinal bleeding [Suzuki et al., 1989; Gaffey et al., 1990; 
Tocci et al., 1990; Imaoka et al., 1994; Nakajima et al., 2004]. A few cases of spontaneous 
regression of HCC after angiography have been reported [Takayasu et al., 1986; Kai et al., 
2010]. The characteristic histology in these cases is coagulative necrosis of tumor cells and 
inflammatory granulation tissue surrounding the coagulative necrosis. Grossly, yellow-
white nodular lesions reflecting coagulative necrosis and brownish lesions reflecting 
inflammatory granulation tissue coexist. 
5. Differential diagnosis by gross appearance 
Various tumors and tumor-like lesions can arise in the liver. Some of these tumors show a 
similar gross appearance to HCC, but some are easily discriminated from HCC on gross 
appearance. 
5.1 Intrahepatic cholangiocellular carcinoma 
Intrahepatic cholangiocellular carcinoma (ICC) is also grossly classified into three types: 
mass-forming type; periductal infiltrating type; and intraductal growth type. Within these 
three types, the mass-forming type is grossly nominated as a differential diagnosis of 
classical HCC. This differential diagnosis is usually easily achieved based on the 
characteristic gross appearance of mass-forming ICC, such as a lobulated, firm and solid  
 
Fig. 13. Cut surface of the mass-forming type of ICC. 
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gray to gray-white mass without a fibrous capsule and often with central necrosis or 
scarring. Scirrhous-type HCC sometimes mimics mass-forming ICC. Intraductal growth-
type HCC often mimics intraductal growth-type ICC and discrimination based on gross 
appearance is difficult. 
5.2 Cholangiolocellular carcinoma 
Cholangiolocarcinoma is a rare neoplasm with a reported incidence of 0.8-1.0% among 
primary liver cancers [Steiner & Higginson, 1959; Shiota et al., 2001]. Cholangiolocarcinoma  
 
Fig. 14. a) Gross appearance of cholangiolocellular carcinoma. b) A tubular cordlike 
anastomosing pattern (as the so-called “antler pattern”) of tumor cells (HE, 100). 
a
b
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is now considered to be derived from Hering’s canal or stem cells, which have intermediate 
features between hepatocytes and bile duct epithelium [Shiota et al., 2001; Kojiro, 2006]. 
Grossly, cholangiolocarcinoma is whitish in color and solid, not encapsulated, and 
resembles cholangiocellular carcinoma. Histologically, tumor cells display eosinophilic 
cytoplasm with ovoid nuclei, and mild atypia, and adopt a tubular cordlike anastomosing 
pattern (so-called antler pattern). These cell cords are continuous with liver cell cords at the 
tumor boundaries, showing a replacing pattern. 
5.3 Hepatocellular adenoma (HCA) 
HCA is a benign liver neoplasm comprising hepatocyte-like tumor cells. The incidence of 
HCA is about 3-4 per 100 000 population in Western countries [Rooks et al., 1979], but is 
 
Fig. 15. a) Gross appearance of hepatocellular adenoma. Focal peliotic change is present. b) 
The nodule consists of tumor cells with abundant hydropic cytoplasm and little atypia 
arranged in a trabecular pattern. 
a
b
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lower in Japan and Asian countries. HCA predominantly occurs in females in the third 
and fourth decades of life, and a close etiological relationship between HCA and oral 
contraceptives has been described [Ishak & Rabin, 1975]. Patients taking androgens for 
Fanconi anemia or acquired anaplastic anemia are also at risk [Velazquez & Alter, 2004]. 
Nonhormonal risk factors include glycogenosis type 1 (von Gierke disease) or 3 (Forbes 
disease), galactosemia, tyrosinemia, familial polyposis coli, and hepatic iron overload 
with β-thalassemia [Shuangshoti & Thaicharoen, 1994]. Obesity has recently been shown 
to be a risk factor for a particular HCA subtype [Bosman et al., 2010]. Grossly, HCA is 
found in the normal liver as a well-demarcated, single or multiple solid tumor. Many 
HCAs are not encapsulated, but some are partly or entirely encapsulated. The tumor is 
yellowish and solid, sometimes associated with necrosis and hemorrhage and/or peliosis 
hepatis-like (pelioid) change and the tumor may be divided by fibrous septa. HCA 
developing close to the liver surface can protrude outside the liver, and is thus susceptible 
to rupture. Histologically, HCA consists of tumor cells with abundant hydropic cytoplasm 
and little atypia arranged in a trabecular pattern of one- or two-cell-thick plates, or round 
eosinophilic tumor cells in a thin trabecular pattern. However, because the sinusoid-like 
blood spaces of the tumor stroma are compressed by the swollen, hydropic tumor cells, 
the trabecular pattern is often obscured and the tumor takes on a solid appearance. The 
tumor contains many arterial and venous tumor vessels, and pelioid change is frequently 
observed. 
5.4 Focal nodular hyperplasia (FNH) 
FNH is not a true neoplasm, but rather a regenerative hyperplastic response of 
hepatocytes, secondary to localized vascular abnormalities with a marked female 
preponderance [Wanless et al., 1985; Fukukura et al., 1998]. This lesion was reported as 
liver cell adenoma for many years before the disease concept of FNH was defined by 
Edmondson in 1958 [Edmondson, 1958]. In two-thirds of cases, FNH is solitary [Wanless 
et al., 1989]. Most lesions are asymptomatic and discovered incidentally during 
laparotomy, autopsy or imaging studies for unrelated symptoms. Although it can now 
be precisely diagnosed by various imaging modalities, FNH is still considered one of the 
common lesions in the differential diagnosis of HCC. The size of FNH varies from a few 
millimeters to over 10 cm in diameter. Grossly, FNH is usually well demarcated, but not 
encapsulated. Most tumors are located close to the liver capsule, and 4.6-20% are 
reportedly pedunculated [Ishak, 1975; Klatskin, 1977; Luciani et al., 2002]. One of the 
characteristic gross features of FNH is the presence of a central fibrous scar with 
radiating fibrous bands dividing the tumor into lobules. The reported incidence of a 
central scar in FNH is 49-62.8% [Nguyen et al., 1999; Kojiro, 2006]. Histologically, 
classical FNH lesions are composed of benign hepatocytes arranged in a trabecular 
pattern of one- or two-cell-thick plates. The central scar consists of dense fibrous tissue 
with many artery-like or vein-like anomalous blood vessels and ductal proliferations. 
Hyperplastic features of hepatocytes in FNH comprise increased cellularity with an 
increased nuclear cytoplasmic ratio, an irregular thin trabecular pattern, and a 
pseudoglandular pattern. Areas showing prominent hyperplastic features mimic well-
differentiated HCC. 
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Fig. 16. a) Gross appearance of FNH. A faint central fibrous scar is apparent in this case. b) 
Artery-like anomalous blood vessels are observed in benign hepatocytes (HE, 40). 
5.5 Hepatocellular neoplasm with massive histiocyte infiltration 
HCC usually contains various degrees of histiocyte infiltration. In the authors’ institution, a case 
of unique hepatocellular nodule with infiltration of abundant histiocytes not previously 
described has been encountered [Kai, 2010]. This case involved a 73-year-old Japanese man with 
diabetes mellitus and mild obesity without viral hepatitis. Histologically, the nodule consisted 
of hepatocyte-like tumor cells and abundant foam cell-type histiocytes that filled up a sinusoid-
like space and formed central loose fibrosis. The tumor showed characteristics of hepatocellular 
adenoma, but contained a focal HCC-like lesion. Similar hepatic nodules have not been 
reported and most of the clinicopathological features and pathology remain unknown. 
a
b
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Fig. 17. a) Gross appearance of hepatocellular neoplasm with massive histiocyte infiltration. 
The nodule was solitary, and the cut surface was whitish with a partly necrotic yellowish 
area. A white myxoid fibrotic area was found at the center of the nodule. b) The nodule 
showed a two-cell pattern: hepatocyte-like cells with rich eosinophilic cytoplasm and little 
nuclear atypia; and light-pink cells considered to be foam cell-type histiocytes (HE, 100). 
5.6 Primary squamous cell carcinoma (SCC) of the liver 
Primary SCC of the liver is very rare. Adenosquamous carcinoma of the liver is also rare 
and reported only sporadically. Various theories have been advanced concerning the 
pathogenesis of SCC of the liver. Chronic inflammation of the bile duct and various  
a
b
www.intechopen.com
 Usual and Unusual Gross Appearance of Hepatocellular Carcinomas 
 
173 
 
 
 
 
 
 
 
 
 
Fig. 18. a) Gross appearance of primary pure SCC of the liver in a patient with no history of 
prior liver insult. b) The nodule consists entirely of SCC tissue with or without keratinization. 
a
b
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Fig. 19. a) A cross-section of inflammatory pseudotumor. Small, white nodules without 
fibrous capsules are observed. b) The tumor comprises chronic inflammatory cells, 
predominantly representing plasma cells (HE, 200). 
a
b
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congenital cysts of the biliary tract have been proposed as etiological factors and continuous 
irritation due to chronic infection, followed by metaplastic changes in the biliary epithelium, 
has been thought to lead to neoplasia [Clements et al., 1990; Nieweg et al., 1992; Banbury et 
al., 1994]. On the other hand, some investigators have suggested that adenosquamous 
carcinoma could arise from squamous metaplasia of adenocarcinoma cells [Barr and 
Hancock, 1975; Tomioka et al., 1987]. Primary SCC of the liver without history of prior liver 
insult suggesting development from squamous metaplasia of adenocarcinoma cells has 
recently been reported [Naik et al., 2009]. Gross appearance depends on the presence or 
absence of congenital cysts. The mass lesion in that case appeared as a solid, whitish firm 
mass without fibrous capsule and with a necrotic area of keratin deposits observed inside 
the nodule. 
5.7 Inflammatory pseudotumor / inflammatory myofibroblastic tumor 
Inflammatory pseudotumor is defined as a benign, non-neoplastic mass consisting of 
fibrous tissue and proliferated myofibroblasts and fibroblasts, with marked infiltration of 
chronic inflammatory cells, predominantly comprising polyclonal plasma cells, 
histiocytes, and macrophages [Coffin et al., 1995]. Lesions of known cause, such as 
healing abscess, tuberculosis, and parasitic infestations, and post-traumatic granulation 
tissue, are excluded from this category. Patients with hepatic lesions generally complain 
of recurrent fever, malaise, abdominal pain, vomiting, and/or diarrhea, but those clinical 
symptoms are not specific. The morphology of inflammatory pseudotumor apparently 
differs according to the stage of inflammation when the lesion is detected. Grossly, the 
lesion appears as a yellowish or whitish nodule with relatively clear margins and a 
widely varying diameter, usually within the range of 1-3 cm. Histological appearance 
also varies considerably, sometimes consisting of nonspecific inflammatory granulation 
tissue with prominent plasma cell infiltration, sometimes associated with necrotic foci, 
and sometimes appearing as a scar-like fibrous nodule with mild inflammatory cell 
infiltration [Kojiro, 2006]. Phlebitis involving peripheral portal or hepatic veins is often 
seen. Rarely, major hepatic and/or portal veins or the vena cava are involved by 
phlebitis mimicking malignant tumor [Broughan et al., 1993; Kai et al., 2007]. Lately, 
IgG4-related disease has been identified as an important subgroup of inflammatory 
pseudotumor [Zen et al., 2004, 2007]. Inflammatory myofibroblastic tumor has recently 
been considered as a possible neoplastic counterpart of inflammatory pseudotumor 
[Coffin et al., 1998], based on the finding that approximately half of inflammatory 
myofibroblastic tumors show an ALK gene translocation [Lawrence et al., 2000; Bridge et 
al., 2001; Chan et al., 2001]. 
6. Conclusion 
This chapter documented the gross appearance and pathology of various types of tumor, 
along with a review of the literature. We believe that the observation of gross features 
with contrasting pathological and clinical findings is helpful in clarifying the nature of 
tumors. In rare cases, a picture of the gross specimen is necessary for case reports. Careful 
storage of good-quality images of gross specimens is thus important in daily clinical 
work. 
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